XEOMIN

Medicinal product

(Invented) name

XEOMIN

Active substance (s)

Clostridium botulinum A tipo neurotoksinas, be kompleksus sudarančių baltymų

Strength

200 V

Pharmaceutical form

milteliai injekciniam tirpalui

Route (s) of administration

leisti į raumenis, leisti į liauką

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

ATC code (s)

M03AX01, Botulinum toxin

Marketing authorisation holder

Merz Pharmaceuticals GmbH, Vokietija

Date of authorisation

2016-05-10

Date of renewal

2020-08-06

Documents

Stage

Perregistruotas

Controlled?

Controlled substance type

Legal basis

8(3)

Procedure number

DE/H/0722/003/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Viename flakone yra	1 vnt.
Clostridium botulinum A tipo neurotoksinas, be kompleksus sudarančių baltymų	200 V

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To
59507	73737	1073737	flakonas	N1	Receptinis	LT/1/14/3514/010	Netiekiama	-	-	No	-	-
65742	80251	1080251	flakonas	N2	Receptinis	LT/1/14/3514/011	Netiekiama	-	-	No	-	-
65743	80252	1080252	flakonas	N3	Receptinis	LT/1/14/3514/012	Netiekiama	-	-	No	-	-
65744	80253	1080253	flakonas	N4	Receptinis	LT/1/14/3514/013	Netiekiama	-	-	No	-	-
65745	80254	1080254	flakonas	N6	Receptinis	LT/1/14/3514/014	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2020-08-06	Perregistruotas
2016-05-10	Registruotas